These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15320982)

  • 1. Current prospects for the development of a therapeutic vaccine for the treatment of HIV type 1 infection.
    Egan MA
    AIDS Res Hum Retroviruses; 2004 Aug; 20(8):794-806. PubMed ID: 15320982
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prospects for vaccine development against HIV infection].
    Kurth R; Binninger D; Ennen J; Denner J; Hartung S; Norley S
    Verh Dtsch Ges Inn Med; 1991; 97():394-402. PubMed ID: 1808921
    [No Abstract]   [Full Text] [Related]  

  • 3. Prospects for HIV-1 therapeutic immunisation and vaccination: the potential contribution of peptide immunogens.
    Sommerfelt MA; Sørensen B
    Expert Opin Biol Ther; 2008 Jun; 8(6):745-57. PubMed ID: 18476786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospects for vaccine protection against HIV-1 infection and AIDS.
    Letvin NL; Barouch DH; Montefiori DC
    Annu Rev Immunol; 2002; 20():73-99. PubMed ID: 11861598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccines and immunology: elucidating immunity to HIV-1 and current prospects for AIDS vaccine development.
    Heeney JL; Hahn BH
    AIDS; 2000; 14 Suppl 3():S125-7. PubMed ID: 11086855
    [No Abstract]   [Full Text] [Related]  

  • 6. [Development of a vaccine against HIV: is this aim accomplishable?].
    Wagner R; Asbach B
    MMW Fortschr Med; 2013 Jun; 155 Suppl 1():36-9. PubMed ID: 23961653
    [No Abstract]   [Full Text] [Related]  

  • 7. Support for the RV144 HIV vaccine trial.
    Belshe R; Franchini G; Girard MP; Gotch F; Kaleebu P; Marthas ML; McChesney MB; McCullough R; Mhalu F; Salmon-Ceron D; Sekaly RP; van Rompay K; Verrier B; Wahren B; Weissenbacher M
    Science; 2004 Jul; 305(5681):177-80; author reply 177-80. PubMed ID: 15247455
    [No Abstract]   [Full Text] [Related]  

  • 8. Cure of HIV infection: is the long wait over?
    Shearer WT
    J Allergy Clin Immunol; 2014 Jul; 134(1):20-2. PubMed ID: 25117800
    [No Abstract]   [Full Text] [Related]  

  • 9. [HIV-1 vaccination--is there hope?].
    Speck RF; Brander C; Kündig TM
    Ther Umsch; 2005 Oct; 62(10):695-702. PubMed ID: 16277037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunisation with gp160 in HIV-1 infection.
    Pontesilli O; Aiuti F
    Lancet; 1999 Sep; 354(9182):948-9. PubMed ID: 10489977
    [No Abstract]   [Full Text] [Related]  

  • 11. Cytokines as adjuvants for improving anti-HIV responses.
    Morrow MP; Weiner DB
    AIDS; 2008 Jan; 22(3):333-8. PubMed ID: 18195559
    [No Abstract]   [Full Text] [Related]  

  • 12. PUBLIC HEALTH. Toward an HIV vaccine: A scientific journey.
    Fauci AS; Marston HD
    Science; 2015 Jul; 349(6246):386-7. PubMed ID: 26206922
    [No Abstract]   [Full Text] [Related]  

  • 13. [Protective mucosal immunity and HIV-1 mucosal vaccine strategy].
    Huang Y; Huang XG; Xu JQ
    Bing Du Xue Bao; 2009 Jul; 25(4):318-22. PubMed ID: 19769168
    [No Abstract]   [Full Text] [Related]  

  • 14. A boost for the immune system.
    TreatmentUpdate; 1998 Nov; 10(9):3-4. PubMed ID: 11365925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential role of the HIV-1 immunogen (Remune) as a therapeutic vaccine in the treatment of HIV infection.
    Fernández-Cruz E; Navarro J; Rodríguez-Sainz C; Gil J; Moreno S; González-Lahoz J; Carbone J
    Expert Rev Vaccines; 2003 Dec; 2(6):739-52. PubMed ID: 14711358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunisation with gp160 in HIV-1 infection.
    Fiala C; Stewart GT
    Lancet; 1999 Sep; 354(9182):948; author reply 949. PubMed ID: 10489976
    [No Abstract]   [Full Text] [Related]  

  • 17. Mucosally-targeted HIV-1 vaccines.
    Wegmann F
    Hum Vaccin; 2011 Sep; 7(9):982-5. PubMed ID: 21892008
    [No Abstract]   [Full Text] [Related]  

  • 18. [Dendritic cell vaccine is a hope for alternative treatment of HIV infection].
    Kahl U
    Lakartidningen; 2003 Jun; 100(25):2224. PubMed ID: 12872511
    [No Abstract]   [Full Text] [Related]  

  • 19. Outstanding questions on HIV vaccine trial.
    Jefferys R; Harrington M
    Science; 2004 Jul; 305(5681):180; author reply 180. PubMed ID: 15247456
    [No Abstract]   [Full Text] [Related]  

  • 20. Current strategies and limitations of HIV vaccines.
    Kawalekar OU; Shedlock DJ; Weiner DB
    Curr Opin Investig Drugs; 2010 Feb; 11(2):192-202. PubMed ID: 20112169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.